ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : Great. Thank you, Catherine. Can you talk a little bit more about the key drivers that underpin that at more than $1 billion run rate that you're talking about for 2025?

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : And just a follow-up on this. Can you talk a little bit about kind of any kind of cadence or timing of growth how to think about quarter-over-quarter given the efforts that you just kind of laid out, including expanding your sales forest, DTC for DAYBUE?

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : Thanks Tom. Another big picture question for me. Can you talk a little bit about how you think about capital deployment and balancing internal priorities like your R&D versus external BD for 2025. I know you were just a quisitive with another asset. So.

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : And I'm sure I'm sure you're going to provide 2025 expense guidance in February. But can you give us any kind of color at this time?

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : What factors do you think limited some of the growth of DAYBUE in 2024.

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : And can you talk a little bit more about how you're going to activate those non-prescribers?

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : How do you drive titration strategies to optimize treatment outcomes? I know that was a theme at the AES conference in December.

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : And I was hoping a segue here and ask about your pipeline, which I think is on display in this presentation here, how do you think about diversifying risk, where you're most excited from a reward perspective? What's lowest risk, in your view, maybe more high risk, high reward. How do you think about that?

Question: Tessa Romero - JPMorgan Chase & Co - Analyst : I think we might have to leave it there. Thank you so much to the entire ACADIA team and thanks everyone for joining.